Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Shares soared on its announcement of offering compounded GLP-1 (Semaglutide) weight-loss medications at prices up to 85% cheaper than branded GLP-1 drugs like Novo Nordisk A/ S NYSE: NVO Ozempic and Wegovy
Who it fits: Patients focused on metabolic optimization and longevity who also want physical recovery support
Combined with its energy-expenditure activity, it promotes balanced metabolic function across multiple pathways in research models
Distribution of results: 86% lost at least 5% of body weight 69% lost at least 10% 50% lost at least 15% 32% lost at least 20% Subgroup analyses examining men specifically show similar percentage weight loss to women, though absolute pounds lost may be higher due to greater starting weights
NAC has a long history of use in clinical settings for liver support because of how quickly it can replenish the livers internal stores
